User profiles for Richard A. Feelders

Richard Feelders

Verified email at erasmusmc.nl
Cited by 19119

[PDF][PDF] Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

…, M van Essen, PP Kooij, RA Feelders… - Journal of Clinical …, 2008 - researchgate.net
Purpose Despite the fact that most gastroenteropancreatic neuroendocrine tumors (GEPNETs)
are slowgrowing, median overall survival (OS) in patients with liver metastases is 2 to 4 …

Cushing's syndrome

A Lacroix, RA Feelders, CA Stratakis, LK Nieman - The lancet, 2015 - thelancet.com
Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's
syndrome, including debilitating morbidities and increased mortality. Genetic and molecular …

Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

…, PP Kooij, WW de Herder, RA Feelders… - Journal of Clinical …, 2005 - ascopubs.org
Purpose There are few treatment options for patients with metastasized or inoperable endocrine
gastroenteropancreatic (GEP) tumors. Chemotherapy can be effective, but the response …

Thyroid hormone concentrations, disease, physical function, and mortality in elderly men

AW van den Beld, TJ Visser, RA Feelders… - The Journal of …, 2005 - academic.oup.com
Context: Physiological changes in thyroid hormone concentrations might be related to
changes in the overall physical function in the elderly. Objective: We determined to what extent …

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

…, JJM Teunissen, BLR Kam, RA Feelders… - Clinical Cancer …, 2017 - AACR
Purpose: Bronchial and gastroenteropancreatic neuroendocrine tumors (NET) are slow-growing
tumors, which frequently express somatostatin receptors on their cell membranes. …

The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics

…, O Chabre, M Pfeifer, RA Feelders… - European journal of …, 2011 - academic.oup.com
Objective The European Registry on Cushing's syndrome (ERCUSYN) is designed to
collect prospective and follow-up data at EU level on Cushing's syndrome (CS). Design and …

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection

…, CL Ronchi, R De Krijger, RA Feelders… - The Journal of …, 2015 - academic.oup.com
Background: Recurrence of adrenocortical carcinoma (ACC) even after complete (R0)
resection occurs frequently. Objective: The aim of this study was to identify markers with …

Glucocorticoid sensitivity in health and disease

…, EFC Van Rossum, RA Feelders - Nature Reviews …, 2013 - nature.com
Glucocorticoids regulate many physiological processes and have an essential role in the
systemic response to stress. For example, gene transcription is modulated by the glucocorticoid…

Cushing's syndrome: epidemiology and developments in disease management

ST Sharma, LK Nieman, RA Feelders - Clinical epidemiology, 2015 - Taylor & Francis
Cushing’s syndrome is a rare disorder resulting from prolonged exposure to excess glucocorticoids.
Early diagnosis and treatment of Cushing’s syndrome is associated with a decrease …

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease

RA Feelders, C de Bruin, AM Pereira… - … England Journal of …, 2010 - Mass Medical Soc
To the Editor: Cushing's disease, which is caused by an adrenocorticotropin-secreting
pituitary adenoma, is associated with increased morbidity and mortality. Currently, there is no …